EdgarLookup

Viridian Therapeutics, Inc.\DE — 4 Filings

198 4 filings on record

This page lists all 4 filings submitted to the SEC by Viridian Therapeutics, Inc.\DE (VRDN), sorted by most recent first. Each row links to the full filing on EdgarLookup. Viridian Therapeutics, Inc.\DE has filed 198 4 documents with the SEC since 2013. To view all SEC filings by Viridian Therapeutics, Inc.\DE, see the full filings list.

Overview All Filings Financials Insiders
All 10-K 10-K/A 10-Q 10-Q/A 144 3 4 4/A 424B3 424B4 424B5 425 5 8-A12B 8-K 8-K/A ARS CERTNAS CORRESP CT ORDER D D/A DEF 14A DEFA14A DRS DRS/A DRSLTR EFFECT FWP POS AM PRE 14A PRER14A S-1 S-1/A S-1MEF S-3 S-3ASR S-4 S-4/A S-8 S-8 POS SC 13D SC 13D/A SC 13G SC 13G/A SCHEDULE 13D/A SCHEDULE 13G SCHEDULE 13G/A SEC STAFF LETTER UPLOAD
Form Description Accession Number Filed Period
4 4 0001193125-26-092028 Mar 4, 2026 Mar 2, 2026
4 4 0001193125-26-092071 Mar 4, 2026 Mar 2, 2026
4 4 0001193125-26-092074 Mar 4, 2026 Mar 2, 2026
4 4 0001193125-26-092036 Mar 4, 2026 Mar 2, 2026
4 4 0001193125-26-092040 Mar 4, 2026 Mar 2, 2026
4 4 0001193125-26-001097 Jan 2, 2026 Dec 31, 2025
4 OWNERSHIP DOCUMENT 0001104659-25-102606 Oct 27, 2025 Oct 23, 2025
4 4 0000950170-25-093099 Jul 2, 2025 Jul 1, 2025
4 4 0000950170-25-093098 Jul 2, 2025 Jul 1, 2025
4 4 0000950170-25-093102 Jul 2, 2025 Jul 1, 2025
4 4 0000950170-25-093107 Jul 2, 2025 Jul 1, 2025
4 4 0000950170-25-093111 Jul 2, 2025 Jul 1, 2025
4 4 0000950170-25-093118 Jul 2, 2025 Jul 1, 2025
4 OWNERSHIP DOCUMENT 0001104659-25-058580 Jun 11, 2025 Jun 9, 2025
4 4 0000950170-25-052530 Apr 9, 2025 Apr 7, 2025
4 4 0000950170-25-037965 Mar 12, 2025 Mar 10, 2025
4 4 0000950170-25-038004 Mar 12, 2025 Mar 10, 2025
4 4 0000950170-25-032887 Mar 4, 2025 Mar 3, 2025
4 4 0000950170-25-032908 Mar 4, 2025 Mar 3, 2025
4 4 0000950170-25-032884 Mar 4, 2025 Mar 3, 2025
4 4 0000950170-25-032891 Mar 4, 2025 Mar 3, 2025
4 4 0000950170-24-110485 Sep 30, 2024 Sep 27, 2024
4 4 0000950170-24-110484 Sep 30, 2024 Sep 27, 2024
4 OWNERSHIP DOCUMENT 0001104659-24-100769 Sep 17, 2024 Sep 13, 2024
4 4 0000950170-24-079038 Jun 28, 2024 Jun 26, 2024
4 4 0000950170-24-079042 Jun 28, 2024 Jun 26, 2024
4 4 0000950170-24-079084 Jun 28, 2024 Jun 26, 2024
4 4 0000950170-24-079037 Jun 28, 2024 Jun 26, 2024
4 4 0000950170-24-079044 Jun 28, 2024 Jun 26, 2024
4 4 0000950170-24-039599 Apr 1, 2024 Mar 28, 2024
4 4 0000950170-24-015205 Feb 14, 2024 Feb 12, 2024
4 4 0000950170-24-012167 Feb 7, 2024 Feb 5, 2024
4 4 0000950170-24-007123 Jan 24, 2024 Jan 22, 2024
4 4 0000950170-23-063124 Nov 13, 2023 Nov 10, 2023
4 4 0000950170-23-057519 Nov 1, 2023 Oct 30, 2023
4 4 0000950170-23-057520 Nov 1, 2023 Oct 30, 2023
4 4 0000950170-23-057692 Nov 1, 2023 Oct 30, 2023
4 4 0000950170-23-049704 Sep 25, 2023 Sep 21, 2023
4 FORM 4 SUBMISSION 0000899243-23-015998 Jun 20, 2023 Jun 15, 2023
4 4 0000950170-23-028727 Jun 16, 2023 Jun 14, 2023
4 4 0000950170-23-028724 Jun 16, 2023 Jun 14, 2023
4 4 0000950170-23-028725 Jun 16, 2023 Jun 14, 2023
4 4 0000950170-23-028721 Jun 16, 2023 Jun 14, 2023
4 FORM 4 SUBMISSION 0000899243-23-014615 Jun 6, 2023 Jun 2, 2023
4 4 0000950170-23-012595 Apr 12, 2023
4 4 0000950170-23-007570 Mar 13, 2023
4 FORM 4 SUBMISSION 0000899243-23-007996 Mar 10, 2023 Mar 9, 2023
4 FORM 4 SUBMISSION 0000899243-23-004592 Feb 10, 2023 Feb 8, 2023
4 FORM 4 SUBMISSION 0000899243-23-004593 Feb 10, 2023 Feb 8, 2023
4 FORM 4 SUBMISSION 0000899243-23-004595 Feb 10, 2023 Feb 8, 2023